Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist®)  by Chen, Zhongying et al.
lsevier.com/locate/yviroVirology 345 (200Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66,
the master donor virus for live attenuated influenza vaccines (FluMistR)
Zhongying Chen, Amy Aspelund, George Kemble, Hong Jin *
MedImmune Vaccines, 297 North Bernardo Avenue, Mountain View, CA 94043, USA
Received 31 August 2005; returned to author for revision 27 September 2005; accepted 5 October 2005
Available online 10 November 2005Abstract
Cold adapted (ca) B/Ann Arbor/1/66 is the master donor virus for the influenza B (MDV-B) vaccine component of the live attenuated influenza
vaccine (FluMistR). The six internal genes contributed by MDV-B confer the characteristic cold-adapted (ca), temperature-sensitive (ts) and
attenuated (att) phenotypes to the vaccine strains. Previously, it has been determined that the PA and NP segments of MDV-B control the ts
phenotype while the att phenotype requires the M segment in addition to PA and NP. Here, we show that the PA, NP and PB2 segments are
responsible for the ca phenotype of MDV-B when examined in chicken cell lines. Five loci in three RNA segments, R630 in PB2, M431 in PA and
A114, H410 and T509 in NP, are sufficient to allow efficient virus growth at 25 -C. Substitution of these five amino acids with wt (wild type)
residues completely reverted the MDV-B ca phenotype. Conversely, introduction of these five ca amino acids into B/Yamanashi/166/98 imparted
the ca phenotype to this heterologous wt virus. In addition, we also found that the MDV-B M1 gene affected virus replication in chicken cells at
33 and 37 -C. Recombinant viruses containing the two MDV-B M1 residues (Q159, V183) replicated less efficiently than those containing wt M1
residues (H159, M183) at 33 and 37 -C, implicating the role of the MDV-B M segment to the att phenotype. The complexity of the multigenic
signatures controlling the ca, ts and att phenotypes of MDV-B provides the molecular basis for the observed genetic stability of the FluMistR
vaccines.
D 2005 Elsevier Inc. All rights reserved.Keywords: FluMistR; Influenza B virus; B/Ann Arbor/1/66 strain; Cold-adaptation; Reverse geneticsIntroduction
In the U.S., annual influenza epidemics are responsible for
approximately 36,000 deaths and over 100,000 hospitalizations
per year. Occasional worldwide pandemics can escalate the
number of deaths into the millions (Simonsen et al., 2000;
Thompson et al., 2003). Human influenza epidemics are
usually caused by type A and type B influenza viruses. The
host range of influenza B viruses is very restricted and these
viruses have only been isolated from humans and seals. The
emergence of new influenza B strains is mainly driven by
antigenic drift due to amino acid changes in the hemagglutinin
(HA) and neuraminidase (NA) proteins and occasionally by
reassortment among different strains of influenza B virus
(McCullers et al., 1999).0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.10.005
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E-mail address: jinh@medimmune.com (H. Jin).Vaccination is the most effective means to prevent illness
and complications caused by influenza infection. The
FluMistR vaccine licensed in 2003 in the U.S. is a live,
attenuated, trivalent influenza vaccine that effectively protects
people from influenza illness (Belshe and Gruber, 2001; Belshe
et al., 2004; Murphy and Coelingh, 2002). FluMistR contains
two influenza A virus strains (H1N1 and H3N2) and one
influenza B strain that are frequently updated based on the
epidemiological studies and recommendations of the CDC and
FDA. Each vaccine strain of FluMist is a 6:2 genetic
reassortant that contains the six internal gene segments (PB2,
PB1, PA, NP, M and NS) derived from the master donor virus
for type A influenza viruses, MDV-A (ca A/Ann Arbor/6/60),
or the master donor virus for type B influenza viruses, MDV-B
(ca B/Ann Arbor/1/66), and the HA and NA gene segments
from a currently circulating wild type (wt) strain. The six
internal gene segments from MDV reproducibly confer the
attenuation and safety features to the vaccine strains. Similar to
MDV-A, MDV-B was originally derived by serial passage of6) 416 – 423
www.e
Fig. 1. Virus growth comparison of MDV-B and wt A/AA/1/66 in CEK cells.
CEK cells were infected with MDV-B and wt B/AA/1/66 at an MOI of 0.001
and incubated at 33 or 25 -C. At the indicated times, the infected cell culture
supernatants were harvested, and infectious virus particles were determined by
plaque assay. The data represent the means of three independent experiments
with standard deviations less than 10%.
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reduced temperatures in primary chicken kidney (PCK) cells
(Maassab, 1967; Maassab et al., 1986). The resulting ca B/AA/
1/66 grows efficiently at 25 -C (cold-adapted, ca), but its
growth is restricted at 37 -C (temperature-sensitive, ts). In
addition, MDV-B replicates in the upper respiratory tract of
ferrets but inefficiently in their lungs (attenuated, att) (Belshe
and Gruber, 2001; Murphy and Coelingh, 2002).
The ca and ts phenotypes of MDV-B are believed to
contribute to the biological activity of the vaccine by
facilitating efficient replication in the upper airways without
producing clinical disease. The genetic basis of the ts and att
phenotypes has only recently been established. Earlier studies
using reassortment techniques implicated PA in the ts and att
phenotypes of B/AA/1/66 (Donabedian et al., 1987). Using a
plasmid-based reverse genetics system, the ts loci of MDV-B
have since been mapped to three residues, one in PA (M431)
and two in NP (A114 and H410). These three ts loci in
combination with two amino acids in M1 (Q159 and V183)
contribute to the expression of the att phenotype (Hoffmann
et al., 2005).
The genetic signature controlling the ca phenotype of
MDV-B has not yet been established. A previous study using
classical reassortment technology showed that the PA segment
from ca B/AA/1/66 could transfer the ts, but not the ca,
phenotype to a heterologous wt strain, implying that a genetic
difference exists between the ts and ca phenotypes (Donabe-
dian et al., 1987). In this report, a series of recombinant viruses
derived from MDV-B were constructed and their ca pheno-
types analyzed. It was determined that five loci in three RNA
segments, including the three ts loci in PA and NP plus two
additional loci found in PB2 (R630) and NP (T509), were
required for controlling the ca phenotype. In addition, the
contribution of the M1 gene to virus growth in vitro was also
determined.
Results
Recombinant MDV-B exhibits the ca phenotype
Plasmid rescue systems have allowed the mapping of the ts
and att phenotypes of MDV-B by analyzing the biological
properties of MDV-B and isogenic recombinants with defined
mutations (Hoffmann et al., 2005). To characterize the ca
phenotype, the growth of recombinant MDV-B and wt B/AA/1/
66 (wt B/AA) in chicken embryo kidney (CEK) cells at 25 -C
was compared to their growth at 33 -C. The CEK cells were
infected with MDV-B or wt B/AA at an MOI of 0.001 and
incubated at 33 or 25 -C. Virus supernatants were collected
daily for 4 days and the quantity of virus was measured by
plaque assay (Fig. 1). Both MDV-B and wt B/AA grew well at
33 -C, reaching titers of approximately 7.0 log10PFU/ml after
2–3 days of infection. In contrast, the kinetics and extent of
replication of wt B/AA at 25 -C were significantly decreased
compared to MDV-B. At 3 days postinfection, the titer of
MDV-B at 25 -C was similar to its titer at 33 -C, while the titer
of wt B/AA/1/66 was approximately 3.5 log10PFU/ml lowerthan its titer at 33 -C. Thus, MDV-B exhibited the ca
phenotype in CEK cells while wt B/AA/1/66 did not. This
difference was used to further evaluate the ca phenotype of
MDV-B in this study.
Altering nine amino acids in MDV-B completely reverts the ca
phenotype
MDV-B contains eight amino acids that are not present in
any other wt influenza B strains and one that was only
identified in one wt strain (Hoffmann et al., 2005). These
residues are located in the PB2 (R630), PA (M431, H497), NP
(A55, A114, H410 and T509) and M1 (Q159 and V183) gene
segments. To characterize the effect of these amino acids on the
ca phenotype, sequences encoding these nine wt amino acids
were introduced into MDV-B by site-directed mutagenesis of
the appropriate MDV-B gene segment plasmids. The resulting
recombinant virus, rWt, was produced and examined in CEK
cells for its growth at 25 -C. As shown in Table 1, MDV-B
grew well at both 33 and 25 -C; the titer difference between 33
and 25 -C was only 0.3 log10PFU/ml. The nine amino acid
substitutions incorporated in rWt thus completely reverted the
ca phenotype. Similar to the biologically derived wt B/AA
(Fig. 1), the titer of rWt at 25 -C was only 3.0 log10, which was
4.4 log10 lower than its titer at 33 -C. A recombinant virus
containing seven of the nine amino acid changes (wt PB2/PA/
NP) also replicated poorly at 25 -C, demonstrating that these
seven amino acids were sufficient to revert the ca phenotype of
MDV-B.
The PB2, PA and NP segments of MDV-B synergistically
control the ca phenotype
A series of recombinants were constructed to identify
whether the ca phenotype required loci in only one or multiple
gene segments. Replication of these recombinant viruses at 33
and 25 -C in CEK cells was analyzed. As shown in Table 2, all
these recombinant viruses grew similarly at 33 -C. The viruses
containing a single wt gene segment (wt PB2, PA or NP) grew
Table 1
Sequence difference and replication of MDV-B and rWt at different temperatures in CEK cells
Virus Amino acid difference Virus titer (mean log10PFU/ml T SD)
PB2 PA NP M1 33 -C 25 -C Dlog10
630 431 497 55 114 410 509 159 183
MDV-B R M H A A H T Q V 6.7 T 0.2 6.4 T 0.3 0.3
rWt S V Y T V P A H M 7.4 T 0.2 3.0 T 0.3 4.4
wt PB2/PA/NP S V Y T V P A Q V 6.6 T 0.1 2.9 T 0.1 3.7
CEK cells were infected with MDV-B, recombinant wt (rWt) with 9 wt amino acids in PB2, PA, NP and M1 or a virus containing 7 wt amino acids in PB2, PA and
NP (wt PB2/PA/NP) at an MOI of 0.001. After incubation at 33 -C and 25 -C for 3 days, virus titers (Mean log10PFU/ml T SD) were determined by plaque assay and
the data presented are calculated from three independent experiments. The difference in virus titers between the two temperatures is shown as Dlog10. The wt amino
acids are in boldface.
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in titers between 33 and 25 -C ranged from 0.8 to 1.2 log10,
revealing that none of the single wt gene segments was sufficient
to completely revert the ca phenotype. The replications of
reassortants with a combination of wt PB2/PA, PB2/NP or PA/
NP segments were further reduced at 25 -C. In this case, the
difference in virus titers between 33 and 25 -C for each
reassortant ranged from 1.8 to 2.2 log10, showing a partially
reverted ca phenotype. In comparison, the reassortant with all
three wt segments (wt PB2/PA/NP) was much more restricted at
25 -C compared to 33 -C, suggesting that all the three segments
contribute to the complete reversion of the ca phenotype.
The ca phenotype was also confirmed by TCID50 assay on
primary chicken kidney (PCK) cells. The differences in
TCID50 titers between 33 -C and 25 -C (Dlog10) for the
recombinant viruses containing either a single or multiple wt
gene segments are shown in Fig. 2. The introduction of aTable 2
Contribution of wt amino acids to the reversion of the ca phenotype of MDV-B in
MDV-B with wt amino acids PB2 PA NP
630 431 497 55
MDV-B R M H A
wt PB2/PA/NP S V Y T
wt PB2 S – b – –
wt PA – V Y –
wt NP – – – T
wt PB2/PA S V Y –
wt PB2/NP S – – T
wt PA/NP – V Y T
R1 S V – T
R2 S – Y T
R3 S V – T
R4 S V – –
R5 S V – –
R6 S V – –
R7 S V – –
R8 S V – –
R9 S V – –
R10 S V – –
R11 S V – T
R12 S V – T
R13 S V – T
a Recombinant viruses were generated with different wt amino acids introduced in
incubated at 33 and 25 -C for 3 days. Virus titers (mean log10PFU/ml T SD) were
between the two temperatures is shown as Dlog10.
b Residues identical to MDV-B. The wt amino acids are in boldface.single wt gene segment (wt PB2, PA or NP) was not
sufficient to revert the ca phenotype, but did impact virus
replication at 25 -C. Consistent with its growth in CEK cells,
the titer difference between 33 and 25 -C was more than 2.0
log10 for the wt PA/NP reassortant. The two other double wt
gene segment recombinants, wt PB2/PA and wt PB2/NP, also
had restricted replication at 25 -C but to a lesser extent than
wt PA/NP. Only the wt PB2/PA/NP recombinant was able to
completely revert the MDV-B ca phenotype (Dlog10 > 3.0),
confirming that the three wt segments, PB2, PA and NP, are
required to produce a non-ca phenotype.
Five amino acids in PB2, PA and NP of MDV-B control the ca
phenotype
To further map the contribution of each of the seven
amino acids in the PB2, NP and PA proteins to the caCEK cellsa
Virus titer (mean log10PFU/ml T SD)
114 410 509 33 -C 25 -C Dlog10
A H T 6.7 T 0.2 6.4 T 0.3 0.3
V P A 6.6 T 0.1 2.9 T 0.2 3.7
– – – 6.7 T 0.2 5.9 T 0.2 0.8
– – – 6.7 T 0.2 5.7 T 0.2 1.0
V P A 6.5 T 0.3 5.3 T 0.3 1.2
– – – 6.8 T 0.4 5.0 T 0.1 1.8
V P A 6.8 T 0.1 4.6 T 0.2 2.2
V P A 6.7 T 0.1 4.5 T 0.2 2.2
V P A 6.8 T 0.2 3.1 T 0.3 3.7
V P A 6.5 T 0.2 4.0 T 0.1 2.5
– – – 6.9 T 0.0 5.1 T 0.1 1.8
V – – 6.9 T 0.1 4.7 T 0.2 2.2
– P – 6.9 T 0.1 4.7 T 0.1 2.2
– – A 6.9 T 0.1 4.2 T 0.1 2.7
V P – 6.9 T 0.0 4.2 T 0.1 2.7
– P A 6.8 T 0.1 3.9 T 0.1 2.9
V – A 6.7 T 0.1 3.9 T 0.2 2.8
V P A 6.8 T 0.2 3.1 T 0.2 3.7
V P – 7.1 T 0.1 4.3 T 0.2 2.8
V – A 6.9 T 0.0 4.1 T 0.1 2.8
– P A 7.0 T 0.1 3.9 T 0.2 3.1
to MDV-B. CEK cells were infected with these viruses at an MOI of 0.001 and
calculated from three independent experiments. The difference in virus titers
Fig. 3. The five ca loci imparted the ca phenotype to wt B/Yamanashi. wt B/
Yam was rescued from eight wt B/Yamanashi/166/98 plasmids (Hoffmann et
al., 2002). Recombinant B/Yamanashi containing the ca loci in PB2, PA and
NP is designated as B/Yam-ca sites. CEK cells were infected with these two
viruses at an MOI of 0.001 and incubated at 33 and 25 -C for 5 days. Virus
titers were determined by plaque assay on MDCK cells and the mean virus
titers and standard deviations (error bars) are plotted.
Fig. 2. The ca phenotype of MDV-B recombinants in PCK cells. PCK cells on
96-well plates were infected with serially diluted recombinant viruses and
incubated at 33 and 25 -C. After 7 days of incubation, virus titers were
determined by the TCID50 assay. The difference in virus titers (Dlog10TCID50/
ml) between 33 -C and 25 -C was plotted and the error bars represent standard
deviations.
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segments was performed (Table 2). In order to map which
of the two amino acids (M431 and H497) in PA was
important for the ca phenotype, single PA mutations were
examined. The recombinant virus containing the PA-431V
residue and wt PB2/NP, designated R1, exhibited a titer
difference of 3.7 log10 between 33 and 25 -C, which was
similar to the parental wt PB2/PA/NP recombinant. Recom-
binant R2, consisting of PA-497Y and wt PB2/NP, had
reduced difference in virus titer between the two tempera-
tures (Dlog10 = 2.5). These data indicated that M431 in PA
mainly contributed to the ca phenotype. PA-M431 has
previously been shown to be important for the ts and att
phenotypes (Donabedian et al., 1988; Hoffmann et al.,
2005). To analyze the contribution of each NP site,
recombinant viruses containing different NP mutations
together with PB2-630S and PA-431V were tested. Intro-
duction of single NP site mutations (R3–R6) was unable to
completely revert the ca phenotype. Testing of the other
double or triple NP sites mutations clearly indicated that
only R10, containing 3 mutations in NP (A114V, H410P,
T509A), had a reduction in virus titer of 3.7 log10 at 25 -C
that is the same as the wt PB2/PA/NP recombinant. Thus,
the NP-55 site had a minimal effect on the ca phenotype
and the NP-114, 410 and 509 sites all contributed to the ca
phenotype. These data demonstrate that the minimal
requirement for the complete reversion of the ca phenotype
resides in five amino acids, one in PB2 (R630S), one in PA
(M431V) and three in NP (A114V, H410P and T509A).
The five ca loci impart the ca phenotype to a heterologous
influenza B strain
Our results indicated that five amino acids in PB2, PA and
NP of MDV-B controlled the ca phenotype. In order to
determine whether these loci could transfer the ca phenotype
to a heterologous non-ca influenza B virus, sequences
encoding five MDV-B residues in PB2 (R630), PA (M431)and NP (A114, H410 and T509) were introduced into a
recombinant wt B/Yamanashi/166/98 strain (Hoffmann et al.,
2002). Wt B/Yamanashi/166/98 (wt B/Yam) replicated well at
33 -C with a titer of 7.0 log10PFU/ml, but its replication at 25
-C was below the detection limit (Fig. 3). Introduction of the
five ca sites into the PB2, PA and NP of B/Yamanashi/166/98
(B/Yam-ca sites) significantly increased virus growth at 25
-C. B/Yam-ca sites grew slower at 25 -C and reached peak
titers at 5 days postinfection. The growth of B/Yam-ca sites
was significantly improved at 25 -C compared to wt B/Yam,
its titer approached that determined at 33 -C. The titer
difference between its growth at 33 and 25 -C was slightly
greater than MDV-B, which may represent the gene constel-
lation effect caused by a heterologous virus. Nevertheless, the
MDV-B ca loci were able to confer the ca phenotype to a
divergent wt strain.
M1 gene product affects virus growth at higher temperatures
Two amino acids (Q159 and V183) in M1 are unique to
MDV-B as all wt influenza B viruses contain H159 and
M183. Previously, it was shown that these two M1 residues
do not confer the ts phenotype, but contribute to the att
phenotype in ferrets (Hoffmann et al., 2005). The data
obtained from multicycle replication of MDV-B recombinant
viruses in CEK cells indicated that these two M1 residues
affected virus replication at 33 -C. As shown in Table 1,
introduction of wt M1 residues in rWt (wt PB2/PA/NP/M)
increased virus titer at 33 -C by 0.7 log10 compared to the
virus with the wt PB2/PA/NP segments. The effect of these
two M1 residues on virus growth at different temperatures
was further evaluated in CEK cells by comparing the
growth of MDV-B and two non-ts recombinant viruses (wt
PA/NP and wt PB2/PA/NP) with the wt or MDV-B M1
residues. As shown in Fig. 4, the two wt M1 amino acids
(M1-HM) did not affect virus titers at 25 -C, the three
viruses with either MDV-B or wt M1 residues grew
similarly at 25 -C. However, the wt M1 residues increased
virus titers by approximately 1.0 log10 at 33 -C and more
than 2.0 log10 at 37 -C. Thus, the two MDV-B M1 residues
Fig. 5. The effect of MDV-B or wt M1 residues on virus growth in CEK cells
at 33 -C. (A) Growth kinetics of viruses containing MDV-B or wt M1
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the higher temperatures.
M1-M183 is sufficient to increase the growth of 6:2 vaccine
strains at 33 -C
To determine the effect of the two M1 residues on the growth
of influenza B vaccine strains, 6:2 B/HongKong/330/01 (B/
Victorial lineage) and 6:2 B/Yamanashi/166/98 (B/Yamagata
lineage) containing the two M1 residues derived from wt or
MDV-B were generated and their replication in CEK cells at 33
-C examined (Fig. 5A). As expected, MDV-B with the two wt
M1 residues (MDV-B M1-HM) achieved a titer slightly higher
thanMDV-B. Remarkably, 6:2 B/Hongkong/330/01 (6:2 B/HK)
only reached a titer of 4.5 log10 at 3 days postinfection,
approximately 2.0 log10 lower than MDV-B. Introduction of
the two wt M1 residues (M1-HM) into 6:2 B/HK significantly
increased virus replication at 33 -C. 6:2 B/Yamanashi/166/98
(6:2 B/Yam), a type B influenza virus from a different HA
lineage, also showed a reduced virus titer of approximately 1.0
log10 at 33 -C 3 days postinfection compared to MDV-B and 6:2
B/Yam with a M1-HM change. These data indicate that the HA
and NA from a heterologous wt virus differentially affect the
growth of the 6:2 reassortant virus in CEK cells. Nevertheless,
the two wt M1 residues increased the titers of 6:2 B/HK (B/HK
M1-HM) and 6:2 B/Yam (B/Yam M1-HM) by 2.0 log10 and 1.0residues. CEK cells were infected with each virus at an MOI of 0.001 and
incubated at 33 -C and virus titers in the supernatants collected at 1, 2 and 3
days postinfection (dpi) were determined by plaque assay. The values are
means of three independent experiments and the error bars indicate the
standard deviation (SD). (B) Single M1 substitution mutations were introduced
into MDV-B (lanes 1–4), 6:2 B/Hongkong/330/01 (lanes 5–8), 6:2 B
Yamanashi/166/98 (lanes 9–12) and wt B/Yamanashi/166/98 (lanes 13–16
and their replication at 33 -C in CEK cells was determined.
Fig. 4. The effect of the MDV-B and wt M gene on virus replication in CEK
cells at 25, 33 and 37 -C. CEK cells were infected at an MOI of 0.001 with
MDV-B and its mutants (wt PA/NP and wt PB2/PA/NP) each containing MDV-
B M1 gene segment (QV) or the MDV-B M1 gene segment containing the two
wt M1 residue substitutions (HM). Infected cells were incubated at 25, 33 or 37
-C for 3 days. Virus titers in culture supernatants were determined by plaque
assay on MDCK cells and mean virus titers and standard deviations are plotted./
)log10, respectively. Thus, the unique Q159 and V183 residues in
the M1 of MDV-B reduced virus growth at 33 -C compared to
viruses with wt amino acids at these positions.
To analyze the individual contribution to virus growth of
each of these two amino acids in the M1 protein, single M1
substitution mutations, encoding a Q159H or V183M change,
were introduced into the M1 gene of MDV-B, 6:2 B/HK and
6:2 B/Yam (Fig. 5B). The Q159H change alone had little effect
on the virus titer (compare columns 1 and 2, 5 and 6, 9 and 10),
but the V183M mutation by itself increased the titer to the same
extent as the double mutations (compare columns 3 and 4, 7
and 8, 11 and 12). Conversely, substitution of M183 by V183
in the M1 of wt B/Yam significantly reduced the titer (columns
13 and 14). H159Q only reduced the titer slightly (compare
columns 15 and 16). Therefore, M1-V183 was identified as the
residue that is primarily responsible for the reduced virus
growth at 33 -C.
Discussion
By comparing replication of MDV-B recombinant viruses in
CEK and PCK cells at 25 and 33 -C, we mapped the ca loci to
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R630 in PB2, M431 in PA, A114, H410 and T509 in NP of
MDV-B. The genetic signatures of the ts and ca phenotypes
overlap in the PA and NP segments, but differed slightly in that
the T509 residue in NP is needed for expression of ca but not
the ts phenotype. In addition, R630 in PB2 is also required for
the expression of the ca phenotype.
The PB1, PB2 and PA proteins constitute the viral
polymerase complex responsible for viral RNA transcription
and replication (Lamb and Krug, 2001; Neumann et al., 2004),
where both processes utilize RNP templates in which the RNA
is encapsidated by NP proteins. The mapping of the ca
phenotype to residues located in the PB2, PA and NP proteins
suggests that the cold adaptation process may have modified
the polymerase proteins to enable them to function more
efficiently at lower temperatures. Molecular studies on the
functions of each of the influenza B virus polymerases are very
limited and our knowledge of influenza virus polymerase
proteins and their functions is largely based on studies of the
influenza A viruses. The sequences of the three polymerase
proteins and NP are highly conserved between the influenza A
and B viruses and are considered to be functionally equivalent
(Crescenzo-Chaigne et al., 1999; Jambrina et al., 1997). Our
studies on the cold adapted influenza A/AA/6/60 master donor
virus used for influenza A component of FluMistR vaccines
(MDV-A) have mapped the amino acids responsible for the
expression of the ts and att phenotypes to the five residues:
E391, G581 and A661 in PB1, S265 in PB2 and G34 in NP
(Jin et al., 2003). These sites do not overlap with the ts and ca
sites mapped on the MDV-B strain, indicating that the cold-
adaptation process resulted in different changes to the virus
replication machinery.
The cold adaptation process did not affect the MDV-B PB1
protein, which contains conserved motifs characteristic of
RNA-dependent RNA polymerases (Argos, 1988; Biswas and
Nayak, 1994). PB2 is responsible for recognition and binding
of the cap structure of host mRNAs required for RNA
transcription initiation (Fechter et al., 2003; Gastaminza et
al., 2003; Poole et al., 2004). Interestingly, the PB2-627 residue
that is near the R630 locus was recently reported to affect viral
replication efficiency of A/HongKong/486/97 H5N1 influenza
A virus in mouse cell lines and its virulence and organ tropism
in mice (Shinya et al., 2004). It remains to be determined how
the residue 630 in PB2 affects virus replication in a
temperature-dependent manner. The exact role of PA is less
well understood, but it is known that PA is essential for both
RNA transcription and replication (Perales et al., 2000; Huarte
et al., 2003). The C-terminal region of PA (H510A, R638A)
has been implicated in endonuclease cleavage of the capped
RNA primers and transcription elongation during RNA
synthesis (Fodor and Smith, 2004; Fodor et al., 2002, 2003)
and an earlier study with ca A/AA/6/60 (MDV-A) has
implicated the involvement of the PA gene in conferring the
ca phenotype to the MDV-A strain (Snyder et al., 1988).
However, whether the PA gene contributes to the ca phenotype
of influenza A and B viruses in general remains to be
determined. NP has multiple functions in viral RNA transcrip-tion, replication and intracellular trafficking by interacting with
a wide variety of viral and cellular factors, including the RNA,
PB1, PB2, M1 and cellular polypeptides (Portela and Digard,
2002). The A114, H410 and T509 residues in the NP are
located in the RNA- and PB2-binding regions; changes at these
locations might affect its interaction with viral proteins and
RNA. Further studies are needed to establish which stages of
viral RNA replication are impacted by these changes.
In this study, we also discovered the impact of the MDV-B
M1 protein on virus replication at 33 and 37 -C in chicken
cells. Substitution of the two MDV-B M1 amino acids with
those of wt (Q159H, V183M) significantly increased virus
replication at the higher temperatures. Conversely, introduction
of Q159 and V183 into a heterologous B/Yamanashi virus
decreased virus growth. However, these two MDV-B specific
M1 residues (Q159 and V183) did not affect virus replication at
25 -C. The effect of the two MDV-B amino acids on virus
growth at 33 and 37 -C was not apparent in MDCK cells
compared to PCK or CEK cells (Hoffmann et al., 2005). A
previous report also showed that the non-ts revertants isolated
from MDCK cells still retained the ca and ts phenotypes when
evaluated in PCK cells (Maassab et al., 1981). MDV-B was
originally adapted to grow at 25 -C in PCK cells. It is possible
that the cold adaptation process has made it grow efficiently at
25 -C but less well at 33 -C in the avian cells. The difference in
virus growth between the avian and canine cells implicates that
virus replication might be influenced by host specific factors.
The M1 matrix protein is a major structural component of
influenza viruses that lies underneath the envelopes of virions
(Lamb and Krug, 2001) and plays a critical role in many
aspects of virus replication. M1 promotes nucleo-cytoplasmic
export of viral RNPs through its interaction with vRNP and
NEP and prevents the reentry of vRNP into the nucleus (Cros
and Palese, 2003). The M1 protein also plays a crucial role in
virus assembly and budding probably by interacting with
RNPs, host cell membrane and the cytoplasmic tails of viral
glycoproteins on the plasma membrane (Barman et al., 2001;
Nayak et al., 2004). Based on these findings, M1 is clearly
important for viral morphogenesis and growth (Baez et al.,
1980; Bourmakina and Garcia-Sastre, 2003; Yasuda et al.,
1993). The conserved H159 residue in M1 found in both
influenza A and B viruses is part of a zinc finger motif
(Wakefield and Brownlee, 1989). MDV-B that lacks the zinc-
binding motif due to the H159Q change does not have a
significant defect in virus growth, confirming that the zinc-
binding motif is not essential for influenza B virus growth in
vitro (Hui et al., 2003; Liu and Ye, 2002). Although the V183
residue in M1 is primarily responsible for temperature-
dependent replication, both Q159 and V183 are important for
the att phenotype (Hoffmann et al., 2005). We found that
recombinant viruses containing the MDV-B M segment were
not efficient in undergoing multiple replication cycles at 37 -C.
The effect of these two residues on virus assembly at higher
temperatures is under investigation.
In conclusion, the genetic basis for the characteristic ca, ts
and att phenotypes of MDV-B has now been mapped using the
plasmid-based reverse genetics system. Residues in PA and NP
Z. Chen et al. / Virology 345 (2006) 416–423422are essential for the expression of all these three phenotypes.
PB2 and M1 were also found to contribute to the expression of
the ca and att phenotypes of MDV-B, respectively. The ca and
ts properties play an important role in enabling vaccine strains
to replicate in the cooler areas of the upper respiratory tract and
induce immune responses, but restrict replication in the lower
respiratory tract that is associated with clinical illness. The data
described here and reported previously (Hoffmann et al., 2005)
describe the genetic signatures of the ts, ca and att phenotypes,
which may serve as surrogate markers of attenuation for
vaccine strains. The complex multigenic basis of all three
phenotypes of MDV-B thus likely accounts for the high degree
of phenotypic stability of FluMistR vaccines.
Material and methods
Cells and viruses
Chicken embryo kidney (CEK) cells were obtained from
Charles River Laboratories (North Franklin, CT). Primary
chicken kidney (PCK) cells were derived by trypsinization of
the primary chicken kidney tissue and the cell suspensions
were kept in minimal essential medium (MEM) containing 5%
fetal bovine serum (FBS). Madin–Darby canine kidney
(MDCK) cells were originally obtained from European
Collection of Cell Cultures (ECACC) and maintained in
MEM containing 10% FBS.
Cold-adapted (ca) B/Ann Arbor/1/66 (MDV-B) and wild
type (wt) B/Ann Arbor/1/66 strains were obtained from Dr.
H.F. Maassab at University of Michigan (DeBorde et al.,
1988). Recombinant MDV-B and wt B/Yamanashi/166/98
viruses were rescued by the eight-plasmid system as described
previously (Hoffmann et al., 2002, 2005). The HA and NA
cDNAs of wt B/HK/330/01 were amplified by RT-PCR using
vRNA as template and cloned into the BsmBI sites in the
pAD3000 vector. Recombinant 6:2 B/HK/330/01 and 6:2 B/
Yamanashi/166/98 viruses were rescued from the eight
plasmids encoding the six internal gene segments of MDV-B
and the wt HA and NA gene segments. The rescued
recombinant viruses were amplified once in embryonated
chicken eggs and virus titers were determined by plaque assay
on MDCK cells as described previously (Hoffmann et al.,
2005).
Substitution mutations were performed by site-directed
mutagenesis of the respective plasmid cDNAs using the
QuikChange Mutagenesis Kit (Stratagene, La Jolla, CA). The
mutated cDNA clones were sequenced to ensure that the
mutations were introduced correctly and no unwanted muta-
tions were introduced during the mutagenesis reactions.
Cold-adaptation phenotype assay
The ca phenotype was measured by comparing virus growth
at 33 and 25 -C in CEK cells. The confluent CEK cells grown
on 12-well plates were infected with virus at the multiplicity of
infection (MOI) as indicated in the text. After 60 min
incubation at room temperature, virus inocula were removedand replaced with 1.5 ml of MEM and incubated at 33 and 25
-C. Virus supernatants were collected at different times of
postinfection and virus titers were determined by plaque assay.
Virus titers were calculated from a minimum of three
experiments and mean virus titers and standard deviations are
presented. The difference in virus titers at 33 and 25 -C was
used to determine the ca phenotype. The ca phenotype assay
was also performed by virus titration in PCK cells grown on
96-well plates. Following 7 days’ incubation at 33 or 25 -C, the
median infectivity dose and standard deviations (TCID50/ml T
SD) were calculated according to the Karber’s Method
(Lennette, 1995; Hoffmann et al., 2005). The ca phenotype
was defined as the one that exhibited less than 100-fold
difference in virus titers between 33 and 25 -C.
Acknowledgments
We thank Eric Hoffmann for the establishment of the
reverse genetic system for MDV-B and for making recombi-
nant B/Hongkong/330/01 and B/Yamanashi/166/98 viruses,
MedImmune Vaccine’s tissue culture facility for providing
tissue culture cells, members of HJ’s group for discussion and
assistance, Michel Eisenbraun, Bin Lu, Min-Shi Lee and
Richard Spaete for review of the manuscript.
References
Argos, P., 1988. A sequence motif in many polymerases. Nucleic Acids Res.
16, 9909–9916.
Baez, M., Palese, P., Kilbourne, E.D., 1980. Gene composition of high-yielding
influenza vaccine strains obtained by recombination. J. Infect. Dis. 141,
362–365.
Barman, S., Ali, A., Hui, E.K., Adhikary, L., Nayak, D.P., 2001. Transport of
viral proteins to the apical membranes and interaction of matrix protein with
glycoproteins in the assembly of influenza viruses. Virus Res. 77, 61–69.
Belshe, R.B., Gruber, W.C., 2001. Safety, efficacy and effectiveness of
cold-adapted, live, attenuated, trivalent, intranasal influenza vaccine in
adults and children. Philos. Trans. R. Soc. Lond., Ser. B Biol. Sci. 356,
1947–1951.
Belshe, R.B., Nichol, K.L., Black, S.B., Shinefield, H., Cordova, J., Walker, R.,
Hessel, C., Cho, I., Mendelman, P.M., 2004. Safety, efficacy, and
effectiveness of live, attenuated, cold-adapted influenza vaccine in an
indicated population aged 5–49 years. Clin. Infect. Dis. 39, 920–927.
Biswas, S.K., Nayak, D.P., 1994. Mutational analysis of the conserved
motifs of influenza A virus polymerase basic protein 1. J. Virol. 68,
1819–1826.
Bourmakina, S.V., Garcia-Sastre, A., 2003. Reverse genetics studies on the
filamentous morphology of influenza A virus. J. Gen. Virol. 84, 517–527.
Crescenzo-Chaigne, B., Naffakh, N., van der Werf, S., 1999. Comparative
analysis of the ability of the polymerase complexes of influenza viruses
type A, B and C to assemble into functional RNPs that allow expression and
replication of heterotypic model RNA templates in vivo. Virology 265,
342–353.
Cros, J.F., Palese, P., 2003. Trafficking of viral genomic RNA into and out of
the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res. 95,
3–12.
DeBorde, D.C., Donabedian, A.M., Herlocher, M.L., Naeve, C.W., Maassab,
H.F., 1988. Sequence comparison of wild-type and cold-adapted B/Ann
Arbor/1/66 influenza virus genes. Virology 163, 429–443.
Donabedian, A.M., DeBorde, D.C., Maassab, H.F., 1987. Genetics of cold-
adapted B/Ann Arbor/1/66 influenza virus reassortants: the acidic poly-
merase (PA) protein gene confers temperature sensitivity and attenuated
virulence. Microb. Pathog. 3, 97–108.
Z. Chen et al. / Virology 345 (2006) 416–423 423Donabedian, A.M., DeBorde, D.C., Cook, S., Smitka, C.W., Maassab, H.F.,
1988. A mutation in the PA protein gene of cold-adapted B/Ann Arbor/1/66
influenza virus associated with reversion of temperature sensitivity and
attenuated virulence. Virology 163, 444–451.
Fechter, P., Mingay, L., Sharps, J., Chambers, A., Fodor, E., Brownlee,
G.G., 2003. Two aromatic residues in the PB2 subunit of influenza A
RNA polymerase are crucial for cap binding. J. Biol. Chem. 278,
20381–20388.
Fodor, E., Smith, M., 2004. The PA subunit is required for efficient nuclear
accumulation of the PB1 subunit of the influenza A virus RNA polymerase
complex. J. Virol. 78, 9144–9153.
Fodor, E., Crow, M., Mingay, L.J., Deng, T., Sharps, J., Fechter, P., Brownlee,
G.G., 2002. A single amino acid mutation in the PA subunit of the influenza
virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.
J. Virol. 76, 8989–9001.
Fodor, E., Mingay, L.J., Crow, M., Deng, T., Brownlee, G.G., 2003. A single
amino acid mutation in the PA subunit of the influenza virus RNA
polymerase promotes the generation of defective interfering RNAs. J. Virol.
77, 5017–5020.
Gastaminza, P., Perales, B., Falcon, A.M., Ortin, J., 2003. Mutations in the N-
terminal region of influenza virus PB2 protein affect virus RNA replication
but not transcription. J. Virol. 77, 5098–5108.
Hoffmann, E., Mahmood, K., Yang, C.F., Webster, R.G., Greenberg, H.B.,
Kemble, G., 2002. Rescue of influenza B virus from eight plasmids. Proc.
Natl. Acad. Sci. U.S.A. 99, 11411–11416.
Hoffmann, E., Mahmook, K., Chen, Z., Yang, C., Spaete, J., Greenberg, H.B.,
Herlocher, M.L., Jin, H., Kemble, G., 2005. Multiple gene segments control
the temperature sensitivity and attenuation phenotypes of ca B/Ann
Arbor/1/66. J. Virol. 79, 11014–11021.
Huarte, M., Falcon, A., Nakaya, Y., Ortin, J., Garcia-Sastre, A., Nieto, A.,
2003. Threonine 157 of influenza virus PA polymerase subunit modulates
RNA replication in infectious viruses. J. Virol. 77, 6007–6013.
Hui, E.K., Ralston, K., Judd, A.K., Nayak, D.P., 2003. Conserved cysteine and
histidine residues in the putative zinc finger motif of the influenza A virus
M1 protein are not critical for influenza virus replication. J. Gen. Virol. 84,
3105–3113.
Jambrina, E., Barcena, J., Uez, O., Portela, A., 1997. The three subunits of the
polymerase and the nucleoprotein of influenza B virus are the minimum set
of viral proteins required for expression of a model RNA template. Virology
235, 209–217.
Jin, H., Lu, B., Zhou, H., Ma, C., Zhao, J., Yang, C.F., Kemble, G., Greenberg,
H., 2003. Multiple amino acid residues confer temperature sensitivity to
human influenza virus vaccine strains (FluMist) derived from cold-adapted
A/Ann Arbor/6/60. Virology 306, 18–24.
Lamb, R.A., Krug, R.M., 2001. Orthomyxoviridae: the viruses and their
replication. In: Knipe, D.M., Howley, P.M., et al. (Eds.), Fields
Virology, vol. 2. Lippincott Williams and Wilkins, Philadelphia,
pp. 1487–1531.
Lennette, D.H., 1995. General principles for laboratory diagnosis of viral
rickettsial, and chlamydial infections. In: Lennette, E.H., Lennette, D.H.,
Lennette, E.T. (Eds.), Diagnostic Procedures for Viral, Rickettsial, and
Chlamydial Infections. American Public Health Association, Washington.
DC, MD.Liu, T., Ye, Z., 2002. Restriction of viral replication by mutation of the
influenza virus matrix protein. J. Virol. 76, 13055–13061.
Maassab, H.F., 1967. Adaptation and growth characteristics of influenza virus
at 25 degrees C. Nature 213, 612–614.
Maassab, H.F., Monto, A.S., DeBorde, D.C., 1981. Development of
cold-recombinants of influenza virus as live virus vaccines. In:
Nayak, D., Fox, C.F. (Eds.), Genetic Variation Among Influenza Viruses,
ICN-UCLA Symposia on Molecular and Cell Biology, vol. XXII.
Academic Press, London, pp. 617–637.
Maassab, H.F., DeBorde, D.C., Donabedian, A.M., Smitka, C.W., 1986.
Prospects for Type B live attenuated vaccines. In: Kendal, A.P., Patriarca,
P.A. (Eds.), Options for the Control of Influenza. Alan Liss Inc., New York,
pp. 258–271.
McCullers, J.A., Wang, G.C., He, S., Webster, R.G., 1999. Reassortment and
insertion-deletion are strategies for the evolution of influenza B viruses in
nature. J. Virol. 73, 7343–7348.
Murphy, B.R., Coelingh, K., 2002. Principles underlying the development and
use of live attenuated cold-adapted influenza A and B virus vaccines. Viral.
Immunol. 15, 295–323.
Nayak, D.P., Hui, E.K., Barman, S., 2004. Assembly and budding of influenza
virus. Virus Res. 106, 147–165.
Neumann, G., Brownlee, G., Fodor, E., Kawaoka, Y., 2004. Orthomyxovirus
replication, transcription, and polyadenylation. Curr. Top. Microbiol.
Immunol. 283, 121–143.
Perales, B., Sanz-Ezquerro, J.J., Gastaminza, P., Ortega, J., Santaren, J.F., Ortin,
J., Nieto, A., 2000. The replication activity of influenza virus polymerase is
linked to the capacity of the PA subunit to induce proteolysis. J. Virol. 74,
1307–1312.
Poole, E., Elton, D., Medcalf, L., Digard, P., 2004. Functional domains of the
influenza A virus PB2 protein: identification of NP- and PB1-binding sites.
Virology 321, 120–133.
Portela, A., Digard, P., 2002. The influenza virus nucleoprotein: a multifunc-
tional RNA-binding protein pivotal to virus replication. J. Gen. Virol. 83,
723–734.
Shinya, K., Hamm, S., Hatta, M., Ito, H., Ito, T., Kawaoka, Y., 2004. PB2
amino acid at position 627 affects replicative efficiency, but not cell
tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 320,
258–266.
Simonsen, L., Fukuda, K., Schonberger, L.B., Cox, N.J., 2000. The impact of
influenza epidemics on hospitalizations. J. Infect. Dis. 181, 831–837.
Snyder, M.H., Betts, R.F., DeBorde, D., Tierney, E.L., Clements, M.L.,
Herrington, D., Sears, S.D., Dolin, R., Maassab, H.F., Murphy, B.R.,
1988. Four viral genes independently contribute to attenuation of live
influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus
vaccines. J. Virol., 62.
Thompson, W.W., Shay, D.K., Weintraub, E., Brammer, L., Cox, N., Anderson,
L.J., Fukuda, K., 2003. Mortality associated with influenza and respiratory
syncytial virus in the United States. JAMA 289, 179–186.
Wakefield, L., Brownlee, G.G., 1989. RNA-binding properties of influenza A
virus matrix protein M1. Nucleic Acids Res. 17, 8569–8580.
Yasuda, J., Toyoda, T., Nakayama, M., Ishihama, A., 1993. Regulatory effects
of matrix protein variations on influenza virus growth. Arch. Virol. 133,
283–294.
